Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: |
Ketamine |
Note: This renewed consent is valid for two years from 5 May 2019.
Product: |
Ketamine |
Note: This renewed consent is valid for two years from 5 May 2019.
Product: |
RiaSTAP |
Note: This renewed consent is valid for two years from 12 May 2019.
Dated this 29th day of April 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).